Paper Aeroplanes and Compass showing Redefining CSO

Clive Scragg on how Evolve are challenging the traditional paradigm of the CSO.

Having worked with various CSO ‘suppliers’ over the last 25 years and having experienced the client/provider relationship from a client’s perspective, I believe I...
Mark Ward, Operations Director at Star, on taking control of your career

Mark Ward, Operations Director at Star, on taking control of your career

Mark Ward, Operations Director at Star, on the key skills that sales representatives need to develop to stay ahead of the curve. People are the...
Pf Awards logo

Pf Awards: Looking for the brightest talent in pharmaceutical sales and medical devices

Pf Awards, the UK’s premier pharmaceutical sales and medical device awards, are open for entries. Pf Awards are looking for the brightest talent working...
Duane Lacey on Maximise salesforce effectiveness through telemarketing support

Maximise salesforce effectiveness through telemarketing support

Duane Lacey, Managing Director, The Healthcare Partnership, on how telemarketing support boosts your sales team’s performance by enabling improved access to HCPs.    How does your telemarketing support enhance sales performance? There is a recognised...
response to the Long Term Plan

HFMA’s Chris Calkin on how the money in the NHS system works

How does the money flow through the NHS? Here’s the inside intelligence. The complicated structure of the NHS is often impenetrable, even to those who...

Performance Associates’ Simon Toy on coaching, leadership & emotional intelligence

Since 2001 Performance Associates (PA) has been working across a range of industries including pharmaceutical sales, healthcare, manufacturing, IT, finance, insurance and FMCG, helping...

Martin Anderson, owner of Carrot Recruitment, on how to negotiate your way through a...

Today’s pharmaceutical and healthcare field teams are operating within increasingly challenging business environments, as companies relentlessly pursue new ways to optimise the commercialisation of...

CHASE Graduate Academy: Diving into the graduate talent pool

Words by Graham Hawthorn, Managing Director and Kate O’Neill, Graduate Recruitment Lead With over 2 million students studying at more than 130 UK Universities, the...

Is being easily influenced really that bad? Asks Ryan Wooller, Head of Business Development...

Ryan Wooller, Head of Business Development at Star, discusses leadership and the importance of influence. Recently, I was talking with a client around the challenges...

Emotional intelligence & the psychology of sales

Don’t keep battering away trying to increase sales, let In-Call Selling with Emotional Intelligence unlock your sales potential. Many of you will have seen the...

Latest articles

Investigational therapy has potential to become first oral GLP-1 receptor agonist for those living with type 2 diabetes

Novo Nordisk presents oral semaglitude data at ENDO

Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data...
Pf Award Winners

Pf Award Winners on the positive patient outcomes that come from working together

The winners of the Joint Working Pf Award 2018, Senior Coloplast Care Nurse Ruth Christer and NHS Partnership Manager, Coloplast, Jonathan Walker, on the...
Brain scan image: Detecting and managing atrial fibrillation

Detecting and managing atrial fibrillation

The ‘Podiatry and Atrial Fibrillation – Save a life, stop a stroke’ webinar was created to improve the detection and management of atrial fibrillation,...

Popular articles

Brain scan image: Detecting and managing atrial fibrillation

Detecting and managing atrial fibrillation

The ‘Podiatry and Atrial Fibrillation – Save a life, stop a stroke’ webinar was created to improve the detection and management of atrial fibrillation,...
Samsung Bioepis Announces Three-year Follow-up Data for Biosimilar ONTRUZANT® (trastuzumab) in Early or Locally Advanced HER2-positive Breast Cancer

Samsung Bioepis announces three-year follow-up data for biosimilar ONTRUZANT® (trastuzumab)

Samsung Bioepis announces three-year follow-up data for biosimilar ONTRUZANT® (trastuzumab) in early or locally advanced HER2-positive breast cancer. Samsung Bioepis has announced the findings of...
The future of genomics

The future of genomics and precision medicine

How is the use of genomics data enhancing our medical understanding and what does this mean for the future of precision medicine? Genomics is one of...
Investigational therapy has potential to become first oral GLP-1 receptor agonist for those living with type 2 diabetes

Novo Nordisk presents oral semaglitude data at ENDO

Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data...
Image of graduates: skills shortage in life sciences

Addressing the skills shortage in life sciences

How can collaboration help to fill the skills shortage gap to ensure that the UK can compete in the global future of life sciences? The...